Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,956 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,331 · Balance 12,956 F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TENET HEALTHCARE CORP
Report date December 29, 2023 · Filed January 02, 2024
Section 16 reporting ended · disclosed 2024-01-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 488,129 |
Reported balance
After 2023-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-12-29 · Exercise / conversion · Acquired 33,586 · Balance 488,129 F1: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F2: Restricted stock units convert into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 474,912 |
Reported balance
After 2023-12-29 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-12-29 · Tax withholding · Disposed 13,217 · Balance 474,912 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. |
| 2023 March Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-12-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-12-29 · Exercise / conversion · Disposed 33,586 · Balance 0 F1: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F4: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend).
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F4: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2026 Filed May 8, 2026 21:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 6,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-214927 · ownership.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,956 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. Read SEC document |
| March 12, 2026 Filed Mar 18, 2026 22:18 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 6,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-114519 · ownership.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,625 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning March 12, 2027. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 22:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2023 March Restricted Stock Units · Derivative | 33,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000176 · doc4.xml · derivative · entry 3 Cancelmi Daniel J · CIK 0001396106 · Former EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,586 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F1 · derivative.exercise_date: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F1 · derivative.expiration_date: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F4 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 22:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 13,217 | $75.57 | $998,808.69 |
DisclosureSEC source: 0001209191-24-000176 · doc4.xml · nonDerivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · Former EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,912 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 22:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 33,586 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-000176 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · Former EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These time-based restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, and vested in their entirety on December 29, 2023 (the business day prior to December 31, 2023, which fell on a weekend). F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Performance-Based Restricted Stock Units · Derivative | 71,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · derivative · entry 12 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On February 26, 2020, the reporting person received a target grant of 44,965 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 71,810 units. The performance-based restricted stock units settled on March 6, 2023. F7 · derivative.exercise_date: On February 26, 2020, the reporting person received a target grant of 44,965 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 71,810 units. The performance-based restricted stock units settled on March 6, 2023. F7 · derivative.expiration_date: On February 26, 2020, the reporting person received a target grant of 44,965 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 71,810 units. The performance-based restricted stock units settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 14,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · derivative · entry 11 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,989 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F6 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F6 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 8,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · derivative · entry 10 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,673 Underlying: Common Stock · 8,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 February Restricted Stock Units · Derivative | 6,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · derivative · entry 9 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,640 Underlying: Common Stock · 6,319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F8 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 28,264 | $59.29 | $1,675,772.56 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 8 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,543 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 71,810 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 7 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: On February 26, 2020, the reporting person received a target grant of 44,965 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 71,810 units. The performance-based restricted stock units settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 5,899 | $59.29 | $349,751.71 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 6 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,997 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 14,989 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 5 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 3,413 | $59.29 | $202,356.77 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 4 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,907 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 8,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 3 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 2,487 | $60.62 | $150,761.94 |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,647 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:21 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 6,319 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017023 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:51 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2023 March Restricted Stock Units · Derivative | 33,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015857 · doc4.xml · derivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,586 Underlying: Common Stock · 33,586 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in in their entirety on December 31, 2023. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in in their entirety on December 31, 2023. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in in their entirety on December 31, 2023. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 11:12 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | PurchaseCommon Stock | 11,000 | $43.07 | $473,770.00 |
DisclosureSEC source: 0001209191-22-054684 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,815 F1 · shares: The shares were purchased in open market broker transactions. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 February Restricted Stock Units · Derivative | 9,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · derivative · entry 9 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 9,044 shares of common stock, as shown in Table I. F5 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 9,044 shares of common stock, as shown in Table I. F5 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 9,044 shares of common stock, as shown in Table I. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 14,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · derivative · entry 8 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,989 Underlying: Common Stock · 14,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 14,989 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F4 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 14,989 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F4 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 14,989 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 3,559 | $85.71 | $305,041.89 |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · nonDerivative · entry 6 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,815 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 9,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · nonDerivative · entry 5 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 9,044 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 5,898 | $85.71 | $505,517.58 |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · nonDerivative · entry 4 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,330 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 14,988 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · nonDerivative · entry 3 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 14,989 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 8,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · derivative · entry 7 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,346 Underlying: Common Stock · 8,672 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 24, 2021, the reporting person received a grant of 26,018 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 8,672 shares of common stock, as shown in Table I. The remaining 17,346 restricted stock units are shown in Table II, of which 8,673 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F1 · derivative.exercise_date: As previously reported, on February 24, 2021, the reporting person received a grant of 26,018 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 8,672 shares of common stock, as shown in Table I. The remaining 17,346 restricted stock units are shown in Table II, of which 8,673 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F1 · derivative.expiration_date: As previously reported, on February 24, 2021, the reporting person received a grant of 26,018 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 8,672 shares of common stock, as shown in Table I. The remaining 17,346 restricted stock units are shown in Table II, of which 8,673 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 3,432 | $81.20 | $278,678.40 |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · nonDerivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,240 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 23:39 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 8,672 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013754 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 24, 2021, the reporting person received a grant of 26,018 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 8,672 shares of common stock, as shown in Table I. The remaining 17,346 restricted stock units are shown in Table II, of which 8,673 are scheduled to vest on each of February 24, 2023, and February 24, 2024. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:31 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2022 February Restricted Stock Units · Derivative | 18,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013324 · doc4.xml · derivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,959 Underlying: Common Stock · 18,959 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2018 February Performance Stock Options (Right to Buy) · Derivative | 70,700 | $20.60 Strike: $20.60 | $1,456,420.00 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · derivative · entry 15 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,700 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F12 · derivative.exercise_date: These derivative securities (stock options) vested and became exercisable on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend). Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 33,059 | $57.29 | $1,893,950.11 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 11 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,000 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F9 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $57.09 to $57.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 27,891 | $56.61 | $1,578,909.51 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 10 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,059 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F8 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $56.06 to $57.06. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 9,750 | $55.67 | $542,782.50 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 9 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,950 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F7 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $55.06 to $56.00. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 70,700 | $20.60 | $1,456,420.00 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 8 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2018 February Performance Stock Options (Right to Buy) · Derivative | 16,126 | $20.60 Strike: $20.60 | $332,195.60 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · derivative · entry 14 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,700 Underlying: Common Stock · 16,126 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F12 · derivative.exercise_date: These derivative securities (stock options) vested and became exercisable on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend). Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2017 March Performance Stock Options (Right to Buy) · Derivative | 89,976 | $18.99 Strike: $18.99 | $1,708,644.24 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · derivative · entry 13 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,976 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F11 · derivative.exercise_date: These derivative securities (stock options) vested and became exercisable on February 28, 2020 (the business day prior to March 1, 2020, which fell on a weekend). Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2012 September Stock Options (Right to Buy) · Derivative | 37,500 | $25.08 Strike: $25.08 | $940,500.00 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · derivative · entry 12 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2022-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. F1 · shares: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. F2 · shares: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F1 · price: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. F10 · derivative.exercise_date: These derivative securities (stock options) vested and became exercisable on each of September 27, 2013 (the business day prior to the first anniversary date, which fell on a weekend), September 26, 2014 (the business day prior to the second anniversary date, which fell on a weekend) and September 28, 2015. F1 · derivative.underlying_shares: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 16,126 | $55.32 | $892,090.32 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 7 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,000 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F6 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $55.05 to $55.38. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 16,126 | $20.60 | $332,195.60 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 6 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 6,403 | $56.05 | $358,888.15 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 5 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,000 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F5 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $55.56 to $56.52. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 83,573 | $55.25 | $4,617,408.25 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 4 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,403 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F4 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $54.56 to $55.55. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 89,976 | $18.99 | $1,708,644.24 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 3 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 37,500 | $55.22 | $2,070,750.00 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 2 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,000 F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $54.53 to $55.45. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 00:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 37,500 | $25.08 | $940,500.00 |
DisclosureSEC source: 0001209191-21-021189 · doc4.xml · nonDerivative · entry 1 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. F2 · kind: This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales. F1 · shares: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. F1 · price: All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2018 February Restricted Stock Units · Derivative | 12,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016453 · doc4.xml · derivative · entry 9 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: As previously reported, on February 28, 2018, the reporting person received a grant of 37,217 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2019, resulting in the vesting and settlement of 12,405 shares of common stock. The second anniversary occurred on February 28, 2020, resulting in the vesting and settlement of 12,406 shares of common stock. The third anniversary occurred on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend), resulting in the vesting and settlement of 12,406 shares of common stock, as shown in Table I. F5 · derivative.exercise_date: As previously reported, on February 28, 2018, the reporting person received a grant of 37,217 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2019, resulting in the vesting and settlement of 12,405 shares of common stock. The second anniversary occurred on February 28, 2020, resulting in the vesting and settlement of 12,406 shares of common stock. The third anniversary occurred on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend), resulting in the vesting and settlement of 12,406 shares of common stock, as shown in Table I. F5 · derivative.expiration_date: As previously reported, on February 28, 2018, the reporting person received a grant of 37,217 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2019, resulting in the vesting and settlement of 12,405 shares of common stock. The second anniversary occurred on February 28, 2020, resulting in the vesting and settlement of 12,406 shares of common stock. The third anniversary occurred on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend), resulting in the vesting and settlement of 12,406 shares of common stock, as shown in Table I. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 February Restricted Stock Units · Derivative | 9,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016453 · doc4.xml · derivative · entry 8 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,044 Underlying: Common Stock · 9,043 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock, as shown in Table I. The remaining 9,044 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F4 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock, as shown in Table I. The remaining 9,044 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F4 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock, as shown in Table I. The remaining 9,044 restricted stock units are shown in Table II and are scheduled to vest on February 27, 2022. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 14,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016453 · doc4.xml · derivative · entry 7 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,977 Underlying: Common Stock · 14,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 29,977 restricted stock units are shown in Table II, of which 14,988 are scheduled to vest on February 26, 2022, and 14,989 are scheduled to vest on February 26, 2023. F1 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 29,977 restricted stock units are shown in Table II, of which 14,988 are scheduled to vest on February 26, 2022, and 14,989 are scheduled to vest on February 26, 2023. F1 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 29,977 restricted stock units are shown in Table II, of which 14,988 are scheduled to vest on February 26, 2022, and 14,989 are scheduled to vest on February 26, 2023. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 4,882 | $51.02 | $249,079.64 |
DisclosureSEC source: 0001209191-21-016453 · doc4.xml · nonDerivative · entry 6 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,000 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 12,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-016453 · doc4.xml · nonDerivative · entry 5 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: As previously reported, on February 28, 2018, the reporting person received a grant of 37,217 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2019, resulting in the vesting and settlement of 12,405 shares of common stock. The second anniversary occurred on February 28, 2020, resulting in the vesting and settlement of 12,406 shares of common stock. The third anniversary occurred on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend), resulting in the vesting and settlement of 12,406 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 3,559 | $51.02 | $181,580.18 |
DisclosureSEC source: 0001209191-21-016453 · doc4.xml · nonDerivative · entry 4 Cancelmi Daniel J · CIK 0001396106 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,476 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.